EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/07/2025
Back to search
Official data from USPTO
CANCERLINQ DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CANCERLINQ DISCOVERY
ST13
US500000087290547Class
42, 44
Filing
87290547
Registration
5376694
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/14/2025
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
01/05/2017
Registration date
01/09/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/02/2017
First use in commerce
10/02/2017
Drawing code
4
Owner type
16
Owner location
CAMBRIDGE, MA
Examiner
KOLODNER, LOUIS
Law office
N40
Current location
TMO LAW OFFICE 122
Holders and representatives
Holders
CANCERLINQ LLC
American Society of Clinical Oncology, Inc.
Representatives
Christopher A. Proskey BROWNWINICK LAW FIRM
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; application service provider featuring software for use in aggregating and analyzing health care and medical data; Scientific and medical researchcollectingcomparinganalyzing of patient-level medical and clinical healthcare data and preparing reports in connection therewith
Class 44
Providing physicians and other healthcare providers information in the field of neoplastic disease preventionscreeningdiagnosis and treatment; providing patient information in the field of neoplastic diseases
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/14/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/14/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/31/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/09/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/06/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/05/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/02/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/01/2017
IUAF
USE AMENDMENT FILED
11/16/2017
EISU
TEAS STATEMENT OF USE RECEIVED
11/16/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/16/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2017
PUBO
PUBLISHED FOR OPPOSITION
03/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2017
DOCK
ASSIGNED TO EXAMINER
01/31/2017
MPMK
NOTICE OF PSEUDO MARK E-MAILED
01/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2017
NWAP
NEW APPLICATION ENTERED
01/09/2017
Continuous trademark protection
Get notified about every new filing that threatens CANCERLINQ DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.